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Abstract
Summary Low vitamin D status is associated with low bone
mass which, in turn, is an important predictor of fracture.
However, data on this relationship in non-Caucasian popula-
tions are scarce. This review shows such an association in the
Chinese population in five of the 11 included studies.
Introduction In the elderly population, the serum 25-
hydroxyvitamin D [25(OH)D] concentration is often inade-
quate. This may cause a lower bone mineral density (BMD),
which is an important predictor of fracture. It is estimated that
by 2050 more than half of all hip fractures worldwide will
occur in Asia. However, data on the relationship between vi-
tamin D status and BMD in a non-Caucasian population are
scarce. Therefore, this study reviews the literature on the rela-
tionship between serum 25(OH)D and BMD in the Chinese
population.
Methods A search was made in PubMed, EMBASE, Web of
Science and Cochrane Library (up to December 2014) to iden-
tify relevant studies using the terms vitamin D status, bone
mineral density, and Chinese.
Results Of the 293 studies identified, 11 fulfilled the inclusion
and exclusion criteria and were analyzed. Mean serum
25(OH)D concentrations ranged from 29-82 nmol/L. In 5 of
the 11 studies, an association was found between vitamin D
status and BMD in the Chinese population.
Conclusion The evidence for a relationship between the se-
rum 25(OH)D concentration and BMD in the middle-aged
and elderly Chinese population living in Asia appears to be
limited and inconsistent.
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Introduction
Vitamin D is important for the development, growth, and
maintenance of a healthy skeleton. Low vitamin D status is
suggested to contribute to bone loss and a low bone mineral
density (BMD) is an important predictor of osteoporotic frac-
tures. Fractures cause impaired quality of life [1], are associ-
ated with increased mortality [2] and are accompanied by high
cost. Bone loss also occurs with aging and the prevalence of
osteoporosis is expected to increase as life expectancy rises.
As a result of a large aging Asian population, it is estimated
that by 2050 more than 50 % of all hip fractures worldwide
will occur in Asia [3]. For example, in Hong Kong, the inci-
dence of hip fractures in older men and women more than
doubled between 1966 and 1985 [4]. In Beijing, the incidence
rate of hip fracture showed a greater increase from 2002 to
2006 than from 1990 to 1992 [5]. Rapidly increasing indus-
trialization and urbanization and reduction of weight-bearing
activities are also associated with an increase in the incidence
of fractures in various areas in Asia [6]. By contrast, during the
past decade a decline has been reported in the incidence of hip
fractures in the more developed regions of Asia (e.g., Hong
Kong). An increase in BMD levels, and a healthier lifestyle
with more physical activity and higher vitamin D status, may
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explain this decline in the incidence of osteoporosis and frac-
tures [7].
Vitamin D3, or cholecalciferol, is primarily produced in the
skin from 7-dehydrocholesterol when exposed to the ultravi-
olet light of the sun (UVB 290–315 nm). It can also be ob-
tained from food, especially fatty fish such as salmon, mack-
erel, eel, and herring and may also be added to food as forti-
fication, e.g., to margarine or milk. In the liver vitamin D3 is
rapidly hydroxylated into 25-hydroxyvitamin D [25(OH)D],
which has low biological activity but is the major circulating
metabolite. It is further hydroxylated in the kidney into 1,25-
dihydroxyvitamin D [1,25(OH)2D], the active form of vitamin
D. This latter hydroxylation is stimulated by parathyroid hor-
mone (PTH). The main effect of 1,25(OH)2D is to stimulate
the intestinal absorption of calcium and phosphate for the
mineralization of the skeleton and for neuromuscular action.
The vitamin D status is usually assessed by measuring the
serum 25(OH)D concentration. Insufficient exposure to sun-
light, covering of the skin, skin pigmentation, a diet that is low
in vitamin D and calcium, and advanced age may negatively
affect vitamin D status. Consequences of severe vitamin D
deficiency include rickets in children and osteomalacia in
adults. In addition, it may lead to secondary hyperparathyroid-
ism, high bone turnover, bone loss, mineralization defects and
it predisposes to fractures. Muscle weakness is another conse-
quence of low 25(OH)D levels.
Studies among Caucasian populations reported the rela-
tionship between vitamin D status and BMD, with evidence
of a positive association [8, 9]. By contrast, low 25(OH)D
concentrations were not correlated with low BMD among
Black individuals [10] and among Black or Hispanic men
[11]. These findings suggest that the relationship between
25(OH)D and BMD may differ by race and ethnicity. There
are various reasons why the relationship between 25(OH)D
and BMD might be different in the Chinese population com-
pared to the Caucasian population. First, genetic factors, for
example variants of vitamin D metabolizing enzymes
CYP24A1 (24-hydroxylase), CYP2R1 (25-hydroxylase), vi-
tamin D binding protein (DBP), and DHCR7 (7-
dehydrocholesterol reductase) can contribute to variation in
25(OH)D concentrations [12, 13]. Second, the average dietary
calcium intake in the Chinese population is low, leading to
secondary hyperparathyroidism and increased turnover of vi-
tamin D metabolites. This may also affect the relationship
between 25(OH)D and BMD. In addition, some lifestyle fac-
tors, e.g., (outdoor) physical activity, may also influence vita-
min D status and BMD, and other lifestyle factors (e.g., be-
havior in the sun) may differ between races as, for example,
the Chinese population tend to have a sun-avoiding behavior.
Information on the relationship between 25(OH)D and
BMD in the Chinese population is scarce but is relevant in
view of the high occurrence of fractures in Asia. In addition,
insight into the relat ionship may help formulate
recommendations for the use of vitamin D supplementation
to prevent osteoporosis.
Therefore, the present study reviews the literature on the
relationship between vitamin D status and BMD in the
middle-aged and older Chinese population. The influence of
the latitude of the area, season, gender, and age on serum
25(OH)D levels is also examined.
Methods
The following electronic databases were searched up to
December 16 2014: PubMed, EMBASE, Web of Science,
and Cochrane Library. Keywords included vitamin D status,
bonemineral density, and Chinese. The search strategy includ-
ed both truncated free-text and MeSH terms and was adjusted
according to different databases. The complete search strategy
is presented in Appendix A. Restriction was made to full-text
articles and abstracts in the English and Dutch language.
Chinese full-text articles with an English abstract were trans-
lated into English. Publications were eligible when reporting
an association between serum 25(OH)D concentrations and
BMD or bone mineral content (BMC) in the Chinese
population.
Data extraction
Extracted from the included studies were the following: (1)
mean (±SD) serum 25(OH)D concentrations (nmol/L), (2)
percentage of subjects with serum 25(OH)D levels ≤25 (or
37.5) nmol/L, between 25 and 50 nmol/L, between 50 and
75 nmol/L, and ≥75 nmol/L, (3) mean (±SD) age of the sub-
jects (years), (4) gender, (5) latitude of the area where the
study was performed (° N), and (6) associations between se-
rum 25(OH)D levels and BMD or BMC.
All serum 25(OH)D concentrations were converted to
nmol/L (1 ng/ml=2.496 nmol/L).
Results
Figure 1 presents the results of the literature search; reasons
for exclusion based on title, abstract, or full text are given. The
characteristics of the selected studies are outlined in Table 1.
Of the 11 included studies most had a cross-sectional de-
sign. Two studies combined a cross-sectional design with a 4-
and 5-year follow-up study [14, 15]. Five studies included
only women [16–20], five studies included both men and
women [15, 21–24], and one study included only men [14].
The mean age of the subjects in most of the studies ranged
from 60 to 76 years. The studies performed in Lanzhou [24]
and Taipei [19] differed from the other studies in that they
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included men and women from age 40 years, and included
both premenopausal and postmenopausal women,
respectively.
Four studies recruited participants randomly [17, 18, 20,
24], and one study reported response rates [22].
One study investigated Malaysian Chinese women living
in Kuala Lumpur, Malaysia (3° N) [16]. Three studies exam-
ined Chinese populations living in Hong Kong, China (22° N)
[14, 21, 22] and one study investigated Chinese women in
Taipei, Taiwan (25° N) [19]. One study reported from
Changsha (28° N) [17], central-south of China, one from
Lanzhou (36° N) [24], north-west of China, and four studies
reported results from the north-east of China, i.e., two from
Beijing (40° N) [18, 20] and two from Shenyang (42° N) [15,
23]. Studies performed outside Asia could not be identified by
the consulted electronic databases.
Of the 11 studies, five reported an association between the
serum 25(OH)D concentration and BMD [14, 15, 17, 18, 21]
while six studies did not observe an association [16, 19, 20,
22–24]; however, various sites for BMD measurement were
used. Most studies measured the BMD at the lumbar spine,
femoral neck, and total hip [14, 17, 20, 21]. Some studies
measured the BMD at one or two of these three sites [15,
16, 19], or some of these sites were combined with the
BMD of the trochanter [21, 23], or different regions in the
hip [22]. In addition, some studies measured the BMD of total
body [18], or of the calcaneus [24]. Finally, one study used
size-adjusted BMC rather than BMD because of the










Records excluded based on title
(n=253)
Gene polymorphism: 121
Chronic disease and bone health e.g.,
HIV, ulcerative colitis, cystic fibrosis: 21
Osteoporosis management: 3
Osteoporosis treatment: 28
Different ethnic group: 10
Calcium and/or nutrition: 21
Traditional Chinese Medicine: 8
Epidemiology of osteoporosis: 2
Vitamin D and PTH: 3








Epidemiology of osteoporosis: 3
Osteoporosis management: 2
Different age: 1
Different ethnic group: 1
Calcium and nutrition: 2
No correlation between vitamin D and 
BMD examined: 8
Conference abstract; insufficient data 
presented: 2
Other reasons: 2
Full-text articles assessed for eligibility
(n=20)




No correlation between vitamin D 
and BMD examined: 4
Risk factor management: 1
No vitamin D included: 2
Different ethnic group: 2
Fig. 1 Summary of the selection
strategy to include articles for the
present review
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comparison in bone health between Chinese people living in
China and Caucasian people living in the UK [23]. All studies
measured the BMD by dual energy X-ray absorptiometry
(DXA), except one study which measured the calcaneal den-
sity by quantitative ultrasound (QUS) [24].
From the five cross-sectional studies with a mean baseline
serum 25(OH)D concentration <50 nmol/L, two studies [17,
18] showed an association between 25(OH)D and BMD,
while three studies [20, 23, 24] did not. From the cross-
sectional studies with a mean baseline 25(OH)D concentration
>50 nmol/L, two studies [14, 21] revealed an association and
three other studies [16, 19, 22] did not.
Although some studies with Caucasian populations ob-
served a threshold serum 25(OH)D with regard to BMD [8],
none of the Chinese studies reported a threshold for the asso-
ciation between serum 25(OH)D concentration and BMD.
Studies performed in north-east and north-west China
showed a high prevalence of low vitamin D status [15, 18,
20, 23]. In these studies the mean serum 25(OH)D concentra-
tion of around 30 nmol/L was remarkably lower than in stud-
ies performed in south-east Asia, which reported a mean se-
rum 25(OH)D concentration >50 nmol/L (Fig. 2).
Seasonal variation in serum 25(OH)D concentration was
not observed in Hong Kong [21], whereas in Taiwan statisti-
cally lower serum 25(OH)D levels were reported when blood
samples were taken in winter [19] (Fig. 2). The remaining
studies included in this review did not examine seasonal var-
iation in 25(OH)D levels.
Some of the included studies reported serum parathyroid
hormone (PTH) [14, 15, 17, 21–23]. A few found a negative
association between PTH and serum 25(OH)D [15, 21, 23] or
between PTH and BMD [14], whereas others did not [17, 22].
In three studies [16, 20, 22], markers of bone turnover, e.g.,
pro-collagen Type 1 N-terminal peptide (P1NP), osteocalcin
(OC), and C-telopeptide β cross link of Type 1 collagen
(CTX-β), were negatively correlated with BMD at various
sites. In two studies, no association was found between bone



























































































































































































































































































































































































































































































































































































































































































































































































































Fig. 2 Mean serum 25(OH)D ± SD (nmol/L) of subjects in different
Chinese studies according to latitude
Arch Osteoporos (2016) 11: 14 Page 5 of 9 14
In woman, one study found a positive association between
physical activity (number of times per week walking with a
load) and BMD at the femoral neck and trochanter [22]. In
another study, low physical activity was associated with serum
25(OH)D concentrations <75 nmol/L [21]. Moreover, moder-
ate physical activity was found to be protective against vita-
min D deficiency in both men and women [24].
Discussion
The present review found no consistent relationship between
the serum 25(OH)D concentration and BMD in the Chinese
population: of the 11 included studies, five reported an asso-
ciation while six did not.
The majority of previous studies on this topic were per-
formed in Caucasian populations. In a study among adults in
the USA, higher 25(OH)D concentrations were associated
with higher BMD among men and women [25]. Also, a pos-
itive association was revealed in the Longitudinal Aging
Study Amsterdam (LASA) performed in the Netherlands,
with a threshold of serum 25(OH)D concentration of about
50–60 nmol/L, i.e., no relation above this level [8]. In a mul-
ticenter trial among postmenopausal women with osteoporo-
sis from 29 countries, of which 1.3 % were of Asian origin, a
significant relationship was found between serum 25(OH)D
levels and BMD [26]. In an Italian population of postmeno-
pausal women a positive correlation was found between
25(OH)D concentrations and BMD at spine and hip [27],
and a weak correlation was shown among ambulatory women
living in Argentina [28]. A study performed in Japan among
postmenopausal women reported that higher 25(OH)D con-
centrations were associated with a higher BMD of femoral
neck [29]. In Manchester (UK), a study conducted among
Pakistani women showed an association between 25(OH)D
concentrations and BMD at femoral neck, total hip, lumbar
spine, and distal radius BMD [30]. A modest positive corre-
lation between the serum 25(OH)D concentration and BMD
was found in White men but not in Black or Hispanic men
[11]. By contrast, other studies did not show an association
[31, 32].
A clear conclusion regarding the outcome of the relation-
ship between serum 25(OH)D and BMDmay be hampered by
heterogeneity in, for example: inclusion and/or exclusion
criteria, selection of participants, adjustments for different var-
iables, site of BMD measurement, study size, and mean base-
line serum 25(OH)D concentration.
Adjustment for confounding variables, regarded as one of
the quality criteria of observational studies [33], differed be-
tween the studies (Table 1). Physical activity, which may have
an effect on BMD, was described in several studies. However,
no study investigated the interaction between physical activity
and the relation between 25(OH)D and BMD. Two large
studies, with 1000 [14] and 10,000 [24] subjects, adjusted
for physical activity. Only the study with higher baseline se-
rum 25(OH)D concentrations [14] found a cross-sectional as-
sociation between serum 25(OH)D and BMD, but not in the
longitudinal design. This may be due to the protective action
of higher serum 25(OH)D concentrations on bone loss, since
more than 50 % of the subjects had serum 25(OH)D concen-
trations >75 nmol/L [14]. In contrast, another smaller longitu-
dinal study [15], with 100 subjects and a mean baseline serum
25(OH)D concentration of 30 nmol/L, did find an association
between 25(OH)D and bone loss.
Of the six cross-sectional studies with a smaller study pop-
ulation, four of them [16, 19, 22, 23] did not show an associ-
ation between 25(OH)D and BMD. However, a smaller study
size may reduce the chance to detect a significant association.
Three studies [16, 19, 22] had a mean baseline 25(OH)D con-
centration of >50 nmol/L and one study [23] of <50 nmol/L.
On the other hand, by far the largest study [24], with a mean
baseline 25(OH)D concentration of <50 nmol/L, also found
no association. Apparently, neither the number of subjects nor
the mean baseline 25(OH)D concentration seem to predict the
outcome of the relationship between serum 25(OH)D and
BMD.
Other variables, such as calcium supplementation and die-
tary calcium intake, were described in several studies [16, 19,
21, 23], but only one study adjusted for calcium supplemen-
tation [17]. Although low calcium intake may induce or ag-
gravate vitamin D insufficiency [9], the influence of calcium is
not clear from these studies.
The included studies did not explore genetic factors, al-
though these may also influence serum 25(OH)D concentra-
tion [12, 13] and, therefore, affect the relationship between
vitamin D status and BMD.
The season of 25(OH)D sampling was not described in
three studies [16, 20, 22]. However, seasonal variation of se-
rum 25(OH)D did not influence BMD values for summer and
winter in Taiwan [19]. This is not remarkable when taking into
account that the mean serum 25(OH)D concentration in
Taiwan is >70 nmol/L, even in the winter.
One study differed from the others by measuring calcaneal
density by quantitative ultrasound; however, this method may
predict fracture risk as well as DXA [34].
Previous studies reported a strong relationship between the
latitude of the area and vitamin D. Serum 25(OH)D levels tend
to increase with decreasing latitude [26, 35]. Given the latitude
of Beijing (40° N) and Shenyang (42° N) with a climate that is
characterized as mild in spring and autumn, hot in summer,
and very cold in winter with low exposure to sunlight, it is not
surprising that serum 25(OH)D levels were lower compared
with the southern regions of China, especially in late winter.
Similar results for low serum 25(OH)D levels were reported in
adolescent girls living in Beijing [36, 37]. However, consid-
ering Malaysia’s latitude of 3° N it is noteworthy that mean
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serum 25(OH)D concentrations of no more than 60 nmol/L
were found in Kuala Lumpur [16]. In addition, in 50 % of the
Malaysian Chinese women, serum 25(OH)D concentrations
<50 nmol/L were reported. The reasons for this are unclear,
but might be explained by sun-avoiding behavior, use of sun-
screen, clothing habits, the hot weather, air pollution, and by
limiting outdoor activities.
The relationship between vitamin D status and gender is
also unclear. Serum 25(OH)D levels in Shenyang women
were higher than in men [23]. In Hong Kong, male sex was
associated with lower serum 25(OH)D levels [21]. By con-
trast, another study in Hong Kong and the study in Lanzhou
observed higher serum 25(OH)D levels in men than in women
[22, 24]. These differences may be due to the type of clothing,
working outside, and the reluctance of women to become
tanned. Previous studies were also inconclusive. A meta-
analysis showed higher serum 25(OH)D levels in women than
in men [38], but another review focusing on the USA revealed
higher vitamin D status in men than in women [39].
A negative correlation between serum 25(OH)D and age
was reported in Beijing [20], which is consistent with the
decrease of serum 25(OH)D levels with aging due to insuffi-
cient sunlight exposure, a decreased functional capacity of the
skin, and reductions in intestinal calcium absorption and renal
function. However, in Taipei no age-related changes in serum
25(OH)D in Chinese women aged 40–72 years were found
[19]. Perhaps the abundant sunshine in Taiwan may have, in
part, compensated for lower 25(OH)D levels, as found in
younger women [40] and in the elderly. Also, the small sample
size of that study may be a reason for the lack of a correlation
between serum 25(OH)D levels and age.
The present study has several limitations. First, few studies
were available and most of the 11 selected studies were cross-
sectional in design and susceptible to bias [33]. Moreover,
most of the studies were not specifically conducted to examine
a relationship between serum 25(OH)D concentrations and
BMD, and not all studies used the same cut-off point to define
vitamin D insufficiency and deficiency. Furthermore, studies
included various bone sites for estimating BMD, and the
methods used to measure BMD differed between the studies.
Finally, comparison of vitamin D status may be hampered by
the high variation of serum 25(OH)D measurement between
laboratories [39, 41–43].
A strength of our review is that it included all studies iden-
tified by four different databases and included not only
English but also Chinese language articles.
In conclusion, the evidence for a positive relationship be-
tween the serum 25(OH)D concentration and BMD in the
middle-aged and older Chinese population living in Asia ap-
pears to be limited and inconsistent. Genetic factors, different
lifestyle habits, including sun-avoiding behavior with the use
of hats and umbrellas, the reluctance of women to become
tanned, a low dietary calcium intake, and the absence of
vitamin D-fortified foods may have an impact on vitamin D
status and its relationship with BMD. Additional intervention
studies are needed to investigate whether vitamin D supple-
mentation can improve BMD in the Chinese population.
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Appendix A: search strategy
PubMed (Bbone mineral density^ [all fields] OR BBone Density^
[Mesh] OR Bbone density^ [all fields] ORBMD [tiab] OR BBoneMineral
Content^ [all fields] OR BBone Mineral Contents^ [all fields] OR Bbone
mineral^ [all fields]) AND (china [tiab] OR Chinese [tiab] OR BChina^
[mesh] OR Bhong kong^ [tiab] OR Bhong kong^ [mesh] OR hongkong
[tw]) AND (BVitamin D^ [mesh] OR Bhydroxyvitamin D^ [all fields] OR
B25(OH)D^ [all fields] OR Bvitamin D^ [all fields] OR Bvitamin D1^ [all
fields] OR Bvitamin D2^ [all fields] OR Bvitamin D3^ [all fields] OR
Bvitamin D4^ [all fields] OR Bvitamin D5^ [all fields] OR vitamind [all
fields] OR Cholecalciferol [all fields] OR Hydroxycholecalciferols [all
fields] OR Ergocalciferols [all fields] OR Hydroxycholecalciferol [all
fields] OR Ergocalciferol [all fields] OR B25-Hydroxyvitamin D 2^ [all
fields] OR Dihydrotachysterol [all fields] OR vitamin d status)
EMBASE (Bbone mineral density .^ti OR *Bone Density/OR Bbone
density .^ti OR BMD.ti,ab OR BBone Mineral Content^.ti OR BBone
Mineral Contents^.ti OR Bbone mineral^.ti AND (exp China/ OR
Chinese.ti,ab OR China.ti,ab OR Bhong kong^.ti,ab OR Hong Kong/OR
hongkong.ti,ab OR Chinese/) AND (exp *Vitamin D/OR
(Bhydroxyvitamin D^OR B25(OH)D^OR Bvitamin D^OR vitamind OR
Cholecalciferol OR Hydroxycholecalciferols OR Ergocalciferols OR
Hydroxycholecalciferol OR Ergocalciferol OR B25-Hydroxyvitamin D
2^ OR Dihydrotachysterol OR Bvitamin D1^ OR Bvitamin D2^ OR
Bvitamin D3^ OR Bvitamin D4^ OR Bvitamin D5^ OR vitamin d
status).ti)
Web of Science (TS = (Bbone mineral density^ OR Bone Density
OR Bbone density^ OR BMD OR BBone Mineral Content^ OR BBone
Mineral Contents^ OR Bbone mineral^) AND TS= (China OR Chinese
OR^ hong kong^ OR Hong Kong OR hongkong) AND TI= (BVitamin
D^ OR Bhydroxyvitamin D^ OR B25(OH)D^ OR Bvitamin D^ OR
vitamind OR Cholecalciferol OR Hydroxycholecalciferols OR
Ergocalciferols OR Hydroxycholecalciferol OR Ergocalciferol OR B25-
Hydroxyvitamin D 2^ OR Dihydrotachysterol OR Bvitamin D1^ OR
Bvitamin D2^OR Bvitamin D3^OR Bvitamin D4^OR Bvitamin D5^ OR
vitamin d status) OR (TS= (Bbone mineral density^ OR Bone Density
OR Bbone density^ OR BMD OR BBone Mineral Content^ OR BBone
Mineral Contents^ OR Bbone mineral^) AND TI= (China OR Chinese
OR Bhong kong^ OR Hong Kong OR hongkong) AND TS= (BVitamin
D^ OR Bhydroxyvitamin D^ OR B25(OH)D^ OR Bvitamin D^ OR
vitamind OR Cholecalciferol OR Hydroxycholecalciferols OR
Ergocalciferols OR Hydroxycholecalciferol OR Ergocalciferol OR B25-
Hydroxyvitamin D 2^ OR Dihydrotachysterol OR Bvitamin D1^ OR
Bvitamin D2^OR Bvitamin D3^OR Bvitamin D4^OR Bvitamin D5^ OR
vitamin d status) OR (TI = (Bbone mineral density^ORBone Density OR
Bbone density^ OR BMD OR BBone Mineral Content^ OR BBone
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Mineral Contents^ OR Bbone mineral^) AND TS= (China OR Chinese
OR Bhong kong^ OR Hong Kong OR hongkong) AND TS= (BVitamin
D^ OR Bhydroxyvitamin D^ OR B25(OH)D^ OR Bvitamin D^ OR
vitamind OR Cholecalciferol OR Hydroxycholecalciferols OR
Ergocalciferols OR Hydroxycholecalciferol OR Ergocalciferol OR B25-
Hydroxyvitamin D 2^ OR Dihydrotachysterol OR Bvitamin D1^ OR
Bvitamin D2^OR Bvitamin D3^OR Bvitamin D4^OR Bvitamin D5^ OR
vitamin d status)
Cochrane Library (Bbone mineral density^ OR Bone Density OR
Bbone density^ OR BMD OR BBone Mineral Content^ OR BBone
Mineral Contents^ OR Bbone mineral^) AND (China OR Chinese OR
Bhong kong^ OR Hong Kong OR hongkong) AND (BVitamin D^ OR
Bhydroxyvitamin D^ OR Bvitamin D^ OR vitamind OR Cholecalciferol
OR Hydroxycholecalciferols OR Ergocalciferols OR
Hydroxycholecalciferol OR Ergocalciferol OR B25-Hydroxyvitamin D
2^ OR Dihydrotachysterol OR Bvitamin D1^ OR Bvitamin D2^ OR
Bvitamin D3^ OR Bvitamin D4^ OR Bvitamin D5^ OR vitamin d status)
Open Access This article is distributed under the terms of the Creative
Commons At t r ibut ion 4 .0 In te rna t ional License (h t tp : / /
creativecommons.org/licenses/by/4.0/), which permits unrestricted use,
distribution, and reproduction in any medium, provided you give appro-
priate credit to the original author(s) and the source, provide a link to the
Creative Commons license, and indicate if changes were made.
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